Literature DB >> 21419437

Long-term results of a prospective, randomized trial comparing retroperitoneoscopic partial versus total adrenalectomy for aldosterone producing adenoma.

Bin Fu1, Xu Zhang, Gong-xian Wang, Bin Lang, Xin Ma, Hong-zhao Li, Bao-jun Wang, Tao-ping Shi, Xing Ai, Hui-xia Zhou, Tao Zheng.   

Abstract

PURPOSE: The indication for laparoscopic total or partial adrenalectomy in patients with aldosterone producing adrenal adenoma remains controversial. We compared retroperitoneoscopic partial and total adrenalectomy for aldosterone producing adrenal adenoma in a prospective, randomized, multicenter trial.
MATERIALS AND METHODS: Patients with aldosterone producing adrenal adenoma were randomized to retroperitoneoscopic partial or total adrenalectomy. Patient characteristics, surgical data, complications and postoperative clinical results were analyzed statistically.
RESULTS: From July 2000 to March 2004, 212 patients were enrolled in this study, including 108 and 104 who underwent total and partial adrenalectomy, respectively. The 2 groups were comparable in patient age, gender, body mass index and tumor site. Mean followup was 96 months in each group. No conversion to open surgery was needed and no major complications developed. Partial adrenalectomy required a shorter operative time than total adrenalectomy but this did not attain statistical significance. Intraoperative blood loss in the partial adrenalectomy group was significant higher than in the total adrenalectomy group (p <0.05) but no patient needed blood transfusion. All patients in each group showed improvement in hypertension, and in all plasma renin activity and aldosterone returned to normal after surgery. No patient required potassium supplements postoperatively. In the total and partial adrenalectomy groups 32 (29.6%) and 29 patients (27.9%), respectively, were prescribed a decreased dose of or fewer antihypertensive medicines at final followup.
CONCLUSIONS: Retroperitoneoscopic partial adrenalectomy is technically safe. It has therapeutic results similar to those of total adrenalectomy in patients with primary aldosteronism due to aldosteronoma.
Copyright © 2011 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21419437     DOI: 10.1016/j.juro.2010.12.051

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  19 in total

1.  SAGES guidelines for minimally invasive treatment of adrenal pathology.

Authors:  Dimitrios Stefanidis; Melanie Goldfarb; Kent W Kercher; William W Hope; William Richardson; Robert D Fanelli
Journal:  Surg Endosc       Date:  2013-09-10       Impact factor: 4.584

Review 2.  Issues in the Diagnosis and Treatment of Primary Aldosteronism.

Authors:  Jacopo Burrello; Silvia Monticone; Fabrizio Buffolo; Martina Tetti; Giuseppe Giraudo; Domenica Schiavone; Franco Veglio; Paolo Mulatero
Journal:  High Blood Press Cardiovasc Prev       Date:  2015-04-09

3.  Discordance between imaging and immunohistochemistry in unilateral primary aldosteronism.

Authors:  Aya T Nanba; Kazutaka Nanba; James B Byrd; James J Shields; Thomas J Giordano; Barbara S Miller; William E Rainey; Richard J Auchus; Adina F Turcu
Journal:  Clin Endocrinol (Oxf)       Date:  2017-09-04       Impact factor: 3.478

4.  Comparative assessment of surgeons' task performance and surgical ergonomics associated with conventional and modified flank positions: a simulation study.

Authors:  Yu Fan; Gaiqing Kong; Yisen Meng; Shutao Tan; Kunlin Wei; Qian Zhang; Jie Jin
Journal:  Surg Endosc       Date:  2014-06-14       Impact factor: 4.584

5.  A retrospective study of laparoscopic unilateral adrenalectomy for primary hyperaldosteronism caused by unilateral adrenal hyperplasia.

Authors:  Shao-bo Jiang; Xu-dong Guo; Han-bo Wang; Ruo-zhen Gong; Hui Xiong; Zheng Wang; Hai-yang Zhang; Xun-bo Jin
Journal:  Int Urol Nephrol       Date:  2014-02-02       Impact factor: 2.370

Review 6.  Approach to the surgical management of primary aldosteronism.

Authors:  Maurizio Iacobone; Marilisa Citton; Giovanni Viel; Gian Paolo Rossi; Donato Nitti
Journal:  Gland Surg       Date:  2015-02

7.  Outcome after surgery for primary hyperaldosteronism may depend on KCNJ5 tumor mutation status: a population-based study from Western Norway.

Authors:  Thomas Arnesen; Nina Glomnes; Siri Strømsøy; Stian Knappskog; Anette Heie; Lars A Akslen; Marianne Grytaas; Jan Erik Varhaug; Oliver Gimm; Michael Brauckhoff
Journal:  Langenbecks Arch Surg       Date:  2013-06-19       Impact factor: 3.445

8.  Percutaneous ablation of functioning adenoma in a patient with a single adrenal gland.

Authors:  Thiago Franchi Nunes; Denis Szejnfeld; Ana Carolina Wanderley Xavier; Suzan Menasce Goldman
Journal:  BMJ Case Rep       Date:  2013-06-03

Review 9.  [Function-preserving adrenalectomy for adrenal tumors].

Authors:  M Brauckhoff; H Dralle
Journal:  Chirurg       Date:  2012-06       Impact factor: 0.955

10.  Effectiveness of partial adrenalectomy for concomitant hypertension in patients with nonfunctional adrenal adenoma.

Authors:  Tianyuan Xu; Leilei Xia; Xianjin Wang; Xiaohua Zhang; Shan Zhong; Liang Qin; Xiang Zhang; Yu Zhu; Zhoujun Shen
Journal:  Int Urol Nephrol       Date:  2014-10-11       Impact factor: 2.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.